Some of the products showed activities against Mycobacterium tuberculosis H37Rv (MTB), multi-drug resistant M. tuberculosis (MDR-TB), and Mycobacterium smegmatis (MC2) relative to ethambutol and pyrazinamide (standard references) [118], and also had acetyl- and butyrylcholinesterase inhibitory properties (of potential use against Alzheimer’s disease) relative to galantamine [119]. This evidence concerns the gene BCHE and early-onset autosomal dominant Alzheimer disease.